glp 1 manufacturers in india GLP-1 Patent Expiry Boosts Indian Pharma | Mahesh Malhotra posted on the topic Which Pharma Players Will Lead
Description
When used with insulin or sulfonylureas, it can cause low blood sugar levels
Erythritol etc
This demonstrates both strong demand and pricing flexibility for offerings that cater to portion control, nutritional balance, and health-conscious eating
The other two appear clean
However, individual responses can vary based on factors like dosage, treatment adherence, and lifestyle habits
